Search research articles
Contact Us
Filters
Showing results (1-10 of 232) with videos related to
Page
of 24
Sort By:
Best Practice & Research. Clinical Gastroenterology
|
May 26, 2004
NOD2/CARD15: relevance in clinical practice
Severine Vermeire
Digestive Diseases (Basel, Switzerland)
|
July 17, 2012
Towards a novel molecular classification of IBD
Severine Vermeire
World Journal of Gastroenterology
|
May 7, 2015
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
Konstantinos Papamichael, Severine Vermeire
Expert Review of Gastroenterology & Hepatology
|
August 20, 2014
Differences between adults and children: genetics and beyond
Thomas Billiet, Severine Vermeire
The Lancet. Gastroenterology & Hepatology
|
August 14, 2018
Differential diagnosis of inflammatory bowel disease: imitations and complications
Krisztina B Gecse, Severine Vermeire
Lancet (London, England)
|
March 4, 2024
Crohn's disease
Michael Dolinger, Joana Torres, Severine Vermeire
Current Drug Targets
|
March 9, 2016
Pharmacokinetic Modeling and Simulation of Biologicals in Inflammatory Bowel Disease: The Dawning of a New Era for Personalized Treatment
Erwin Dreesen, Ann Gils, Severine Vermeire
Gastroenterology
|
March 3, 2009
Biological therapies for inflammatory bowel diseases
Paul Rutgeerts, Severine Vermeire, Gert Van Assche
Trends in Pharmacological Sciences
|
December 6, 2016
Novel Targeted Therapies for Inflammatory Bowel Disease
Mehmet Coskun, Severine Vermeire, Ole Haagen Nielsen
World Journal of Gastroenterology
|
June 3, 2010
Role of genetics in prediction of disease course and response to therapy
Severine Vermeire, Gert Van Assche, Paul Rutgeerts
Page
of 24
Search research articles
Search
Showing results (1-10 of 232) with videos related to
Sort By:
Page
of 24
Best Practice & Research. Clinical Gastroenterology
|
May 26, 2004
NOD2/CARD15: relevance in clinical practice
Severine Vermeire
Digestive Diseases (Basel, Switzerland)
|
July 17, 2012
Towards a novel molecular classification of IBD
Severine Vermeire
World Journal of Gastroenterology
|
May 7, 2015
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
Konstantinos Papamichael, Severine Vermeire
Expert Review of Gastroenterology & Hepatology
|
August 20, 2014
Differences between adults and children: genetics and beyond
Thomas Billiet, Severine Vermeire
The Lancet. Gastroenterology & Hepatology
|
August 14, 2018
Differential diagnosis of inflammatory bowel disease: imitations and complications
Krisztina B Gecse, Severine Vermeire
Lancet (London, England)
|
March 4, 2024
Crohn's disease
Michael Dolinger, Joana Torres, Severine Vermeire
Current Drug Targets
|
March 9, 2016
Pharmacokinetic Modeling and Simulation of Biologicals in Inflammatory Bowel Disease: The Dawning of a New Era for Personalized Treatment
Erwin Dreesen, Ann Gils, Severine Vermeire
Gastroenterology
|
March 3, 2009
Biological therapies for inflammatory bowel diseases
Paul Rutgeerts, Severine Vermeire, Gert Van Assche
Trends in Pharmacological Sciences
|
December 6, 2016
Novel Targeted Therapies for Inflammatory Bowel Disease
Mehmet Coskun, Severine Vermeire, Ole Haagen Nielsen
World Journal of Gastroenterology
|
June 3, 2010
Role of genetics in prediction of disease course and response to therapy
Severine Vermeire, Gert Van Assche, Paul Rutgeerts
Page
of 24